Answers are grounded in this paper and cite their sources.
Background/Objectives: Breast cancer remains a major global health challenge, with the PI3K/AKT/mTOR signaling axis playing a key role in tumor progression. Drug repurposing offers an efficient approach to cancer therapeutics. Niflumic acid (NIF), a selective cyclooxygenase-2 (COX-2) inhibitor, has demonstrated antiproliferative and pro-apoptotic effects against breast cancer cells; however, its therapeutic potential is limited by its poor solubility. This study aimed to develop, optimize, and evaluate NIF-loaded aspasomes (NIF-ASPs) against solid Ehrlich carcinoma (SEC). Methods: NIF-ASPs were optimized via a 21.41 full factorial design. The optimum (A2) formulation was evaluated for entrapment efficiency (EE%), vesicle size (VS), polydispersity index (PDI), zeta potential (ZP), and ex vivo permeation, using the skin as a model lipoidal barrier. Following intraperitoneal administration, the antitumor efficacy and associated changes in PI3K/AKT/mTOR signaling components were evaluated in SEC-bearing mice through RT-qPCR gene expression, biochemical assays, immunohistochemistry, and histopathology. Results: The optimal A2 formula exhibited an EE% of 94.83 ± 0.16%, VS of 205.55 ± 2.05 nm, PDI of 0.49 ± 0.00, ZP of −23.65 ± 0.35 mV, and about a 2.59-fold increase in skin permeation flux versus free NIF suspension. In vivo, A2 was associated with a tumor inhibition rate of 63% (NIF suspension, 51.56%). Molecular and biochemical investigations demonstrated that A2 treatment was accompanied by significant alterations in PI3K/AKT/mTOR-associated molecular markers, characterized by decreased PI3K and p-AKT levels, together with downregulation of AKT and mTOR expression. Additionally, A2 treatment resulted in significant reductions in BCL-2, p-BAD, COX-2, and MDA levels, accompanied by restoration of total antioxidant capacity and a marked increase in cleaved caspase-3 immunoreactivity. Conclusions: NIF-ASPs serve as an efficient delivery platform that significantly enhances the NIF ex vivo skin permeation and are associated with reduced tumor growth accompanied by alterations in the PI3K/AKT/mTOR pathway-related molecular markers, COX-2-related inflammation, and oxidative stress.
No takes yet. Share an insight, caveat, or question.
Mostafa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: